Get started
Author

Eleftheria Tsolaki

Observed names: E Tsolaki, E. Tsolaki, ELEFTHERIA TSOLAKI, Tsolaki, Eleftheria
ORCID: 0000-0003-1463-1754
Observed ORCID: 0000-0003-1463-1754
OpenAlex ID: A5084537623
Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury.
2013 · Angeliki Xagorari, Eleni Siotou, et al. · Europe PMC (PubMed Central) · 76
Stem cell-based regenerative opportunities for the liver: State of the art and beyond
2015 · Eleftheria Tsolaki, Evangelia Yannaki · World Journal of Gastroenterology · 71
PDF
Hematopoietic stem cells and liver regeneration: Differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury
2014 · Eleftheria Tsolaki, Evangelia Athanasiou, et al. · Blood Cells Molecules and Diseases · 51
EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab
2014 · Evangelia Razis, George Pentheroudakis, et al. · Journal of Cancer Research and Clinical Oncology · 36
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials
2013 · George Fountzilas, Urania Dafni, et al. · BMC Cancer · 32
PDF
MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer
2016 · Helen Gogas, Vassiliki Kotoula, et al. · Journal of Translational Medicine · 29
PDF
Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe
2017 · George Fountzilas, Amanda Psyrri, et al. · International Journal of Cancer · 24
PDF
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes
2016 · Vassiliki Kotoula, Vasilios Karavasilis, et al. · Breast Cancer Research and Treatment · 19
Prognostic Significance of ESR1 Gene Amplification, mRNA/Protein Expression and Functional Profiles in High-Risk Early Breast Cancer: A Translational Study of the Hellenic Cooperative Oncology Group (HeCOG)
2013 · George Pentheroudakis, Vassiliki Kotoula, et al. · PLoS ONE · 16
PDF
Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome
2018 · Vassiliki Kotoula, Kalliopi Tsakiri, et al. · Clinical Breast Cancer · 13
Evaluation of Two Highly-Multiplexed Custom Panels for Massively Parallel Semiconductor Sequencing on Paraffin DNA
2015 · Vassiliki Kotoula, Aggeliki Lyberopoulou, et al. · PLoS ONE · 13
PDF
Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer
2021 · GEORGIOS RIGAKOS, EVANGELIA RAZIS, et al. · Anticancer Research · 10
PDF
Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials
2017 · Anna Batistatou, Vassiliki Kotoula, et al. · Clinical Breast Cancer · 9
The fate of BRCA1-related germline mutations in triple-negative breast tumors.
2017 · Vassiliki Kotoula, Florentia Fostira, et al. · PubMed · 7
Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study
2018 · Angelos Koutras, Georgios Lazaridis, et al. · PLoS ONE · 5
PDF
Intact or Broken-apart RNA: An Alternative Concept for ALK Fusion Screening in Non–Small Cell Lung Cancer (NSCLC)
2014 · Vassiliki Kotoula, Mattheos Bobos, et al. · Applied immunohistochemistry & molecular morphology · 5
Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping
2025 · J. Sgouros, A. Eliades, et al. · ESMO Gastrointestinal Oncology · 4
PDF
Adjusting Breast Cancer Patient Prognosis with Non-HER2-Gene Patterns on Chromosome 17
2014 · Vassiliki Kotoula, Mattheos Bobos, et al. · PLoS ONE · 4
PDF
Molecular Alterations in Paired Epithelial Ovarian Tumors in Patients Treated with Neoadjuvant Chemotherapy
2024 · Adamantia Nikolaidi, Eirini Papadopoulou, et al. · Cancers · 2
Mutation profiles of nasopharyngeal carcinomas in South-Eastern European patients
2016 · G. Fountzilas, A. Psyrri, et al. · Annals of Oncology · 1
PDF
Evaluation of the association of HER family members with efficacy of trastuzumab therapy in metastatic breast cancer
2016 · A. Koutras, V. Kotoula, et al. · Annals of Oncology · 1
PDF
Tumor infiltrating lymphocytes and hydrophobic amino acid changes in HER2-positive metastatic breast cancer.
2016 · Vassiliki Kotoula, Eleni Giannoulatou, et al. · Journal of Clinical Oncology · 1
Implications of high tumor infiltrating lymphocytes (TIL) in HER2-positive and triple-negative breast cancer (TNBC).
2015 · Vassiliki Kotoula, Kyriakos Chatzopoulos, et al. · Journal of Clinical Oncology · 1
Abstract 3579: Routinely applicable, highly multiplexed triple-negative breast cancer (TNBC) genotyping
2014 · Vassiliki Kotoula, Kyriaki Papadopoulou, et al. · Cancer Research · 1
PD05-02: Effect of HER2/Topoisomerase II alpha (TOP2A) Gene Status or Protein Expression and Chromosome 17 (CEP17) Polysomy on the Outcome of Breast Cancer Patients Treated with Anthracycline-Containing Dose-Dense Sequential Adjuvant Chemotherapy with or without Paclitaxel – A Pooled Analysis of Two Hellenic Cooperative Oncology Group (HeCOG) Phase III Trials.
2011 · U Dafni, M Bobos, et al. · Cancer Research · 1
Works count: 47
Citation count: 433
H-index: 11
I10-index: 12
Year
Topic
Type